GHH

Cytokinetics Announces Recipients of Its Sixth Annual Communications Grant Program

Retrieved on: 
Monday, January 29, 2024
Woman, ALS Therapy Development Institute, Patient, Heart, GHH, ALS, SAN, ALS TDI, Science, Cardiomyopathy, Patient advocacy, Heart failure, Engagement, HCM, Hypertrophic cardiomyopathy, Caregiver, Cytokinetics, Cardiovascular disease, Heart transplantation, Human, Organization, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its sixth annual Communications Grant Program, intended to support increased capacity in communications, awareness building and community engagement.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its sixth annual Communications Grant Program, intended to support increased capacity in communications, awareness building and community engagement.
  • The grants will support projects to increase access to resources, grow organizational reach and launch educational programs.
  • Cardiomyopathy UK will use the grant to expand Reaching Further, a project aimed at educating those not diagnosed with cardiomyopathy about the symptoms and warning signs.
  • The grant will allow Cardiomyopathy UK to create 15 additional case study stories and refine and optimize the organization’s website.

Former Biogen CEO Michel Vounatsos Joins Quris-AI Board

Retrieved on: 
Thursday, January 4, 2024
MSD, Biology, Teva Pharmaceuticals, Partnership, Drug discovery, Immunology, Drug development, Merck & Co., TEL, Novartis, MBA, GHH, AI, Artificial intelligence, History, Pharmaceutical industry

BOSTON and TEL AVIV, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Quris-AI , an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors, and the appointment of Yossi Ben Amram, former Merck & Co., Inc. (MSD) Regional President, as President of Quris-AI.

Key Points: 
  • BOSTON and TEL AVIV, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Quris-AI , an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, announced the addition of Michel Vounatsos, former CEO of Biogen, to its Board of Directors, and the appointment of Yossi Ben Amram, former Merck & Co., Inc. (MSD) Regional President, as President of Quris-AI.
  • “Adding accomplished pharmaceutical leaders such as Yossi Ben Amram and Michel Vounatsos to our leadership team will be invaluable in our push for a pharma Bio-AI revolution.
  • Michel Vounatsos brings extensive global leadership and management experience in the biopharmaceutical industry, including having served as CEO and member of the Board of Directors of Biogen, Inc. from early 2017 until November 2022.
  • Vounatsos earned his MBA from the HEC School of Management in Paris, France, and his C.S.C.T.

Global Heart Hub and the Global Coalition on Aging launch a Global Position Paper on Heart Valve Disease (HVD) and the Healthy Aging Agenda

Retrieved on: 
Thursday, March 23, 2023
Partnership, UN Decade on Ecosystem Restoration, Prevalence, GCOA, HVD, Health, Policy, Global Coalition Against Pneumonia, Patient engagement in Canada, Organization, Incidence, Patient, Diagnosis, Society, Behavior, GHH, Disease, Medical device, Pharmaceutical industry, Ageing

"The impacts of HVD are all the more tragic because they are largely avoidable," said Michael Hodin, CEO of the GCOA.

Key Points: 
  • "The impacts of HVD are all the more tragic because they are largely avoidable," said Michael Hodin, CEO of the GCOA.
  • "The prevalence and incidence is growing apace with the aging of our society.
  • As population aging accelerates, HVD is growing as a life-threatening health challenge and a costly drain on health systems and public budgets.
  • "This should be a true partnership, empowering people to understand the disease, their treatment options, and long-term care plans."

Global Heart Hub and the Global Coalition on Aging launch a Global Position Paper on Heart Valve Disease (HVD) and the Healthy Aging Agenda

Retrieved on: 
Thursday, March 23, 2023
Partnership, UN Decade on Ecosystem Restoration, Prevalence, GCOA, HVD, Health, Policy, Global Coalition Against Pneumonia, Patient engagement in Canada, Organization, Incidence, Patient, Diagnosis, Society, Behavior, GHH, Disease, Medical device, Pharmaceutical industry, Ageing

"The impacts of HVD are all the more tragic because they are largely avoidable," said Michael Hodin, CEO of the GCOA.

Key Points: 
  • "The impacts of HVD are all the more tragic because they are largely avoidable," said Michael Hodin, CEO of the GCOA.
  • "The prevalence and incidence is growing apace with the aging of our society.
  • As population aging accelerates, HVD is growing as a life-threatening health challenge and a costly drain on health systems and public budgets.
  • "This should be a true partnership, empowering people to understand the disease, their treatment options, and long-term care plans."

Komatsu announces plans to acquire German-based manufacturer GHH Group GmbH

Retrieved on: 
Tuesday, December 20, 2022
Machine Tools, Metalworking & Metallurgy, Engineering, Mining, Minerals, Manufacturing, Natural Resources, Machinery, Mining, Environment, GHH, Growth, Forest, Safety, Workplace, Multimedia, LHD (load, haul, dump machine), Acquisition

Komatsu today announced that it has entered into an agreement to acquire GHH Group GmbH (GHH), a manufacturer of underground mining, tunnelling and special civil engineering equipment headquartered in Gelsenkirchen, Germany.

Key Points: 
  • Komatsu today announced that it has entered into an agreement to acquire GHH Group GmbH (GHH), a manufacturer of underground mining, tunnelling and special civil engineering equipment headquartered in Gelsenkirchen, Germany.
  • View the full release here: https://www.businesswire.com/news/home/20221220005491/en/
    The GHH MK-42 truck is seen operating underground.
  • With this acquisition, Komatsu will add GHH’s factories and rebuild facilities in key markets, in addition to its robust product offerings and talented staff.
  • “GHH is excited to be able to start a new journey with a strong player in the mining world.

Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

Retrieved on: 
Wednesday, November 30, 2022
Respiratory disease, Vaccine, Osteoporosis, Engineering, Health care, CGT, Gene, Partnership, Medtech, Patient, Degenerative disease, Workforce, Bioprocess engineering, GHH, Occupational Safety and Health Act 1994, Cancer, Quality of life, Biosimilar, Immunotherapy, Investment, Pharmaceutical industry, Generic drug, Fine chemical

This standout agreement with Bioventure enables selected Alvotech products to boost our regional and continental strategy and elevates access to complex medicines."

Key Points: 
  • This standout agreement with Bioventure enables selected Alvotech products to boost our regional and continental strategy and elevates access to complex medicines."
  • Licensed biosimilar candidates cover a wide range of therapeutic areas, all characterized by high unmet medical need in the Territory.
  • Bioventure is currently the Middle East and Africa's exclusive license holder for a comprehensive portfolio of biosimilar candidates developed and manufactured by Alvotech, a global biotech company headquartered in Iceland.
  • MiGenTrawas founded in 2021.MiGenTra combines the scientific and manufacturing expertise from both contributing companies, ProBioGen and Minapharm Pharmaceuticals.

Astrix Adds Veteran Life Science IT Executive Leadership to the Board of Directors

Retrieved on: 
Friday, June 3, 2022
Science, GHH, Automation, RED, International development, CEO, Organization, MMD, Merck & Co., Digital, Growth, Technology, MRL, CIO, Compliance, Quality of life, Emerging market, Industry, Merck, Strategic planning, Management, Astrix

RED BANK, N.J., June 3, 2022 /PRNewswire-PRWeb/ -- Astrix, the market-leaders in strategic, technical & staffing services for life science organizations, announced today the appointment of Sandy Tremps to its board of directors. Sandy is a successful industry veteran bringing over 30 years of life sciences IT leadership to Astrix.

Key Points: 
  • RED BANK, N.J., June 3, 2022 /PRNewswire-PRWeb/ -- Astrix, the market-leaders in strategic, technical & staffing services for life science organizations, announced today the appointment of Sandy Tremps to its board of directors.
  • Sandy is a successful industry veteran bringing over 30 years of life sciences IT leadership to Astrix.
  • "There's no better way to drive value for clients than having a successful executive helping guide strategic direction at Astrix.
  • We're excited to have a wildly successful industry veteran like Sandy on board and look forward to her insights & contributions."

Greater Houston Healthconnect Uses InterSystems HealthShare® to Create Largest Known COVID-19 Outcomes Study

Retrieved on: 
Thursday, September 30, 2021
Software, Managed Care, Health, Data Management, Infectious Diseases, Technology, Other Technology, Other Health, Transfer, HIE, Interoperability, Health information exchange, GHH, Efficiency, Risk, Collection, Patient, Pathology, Data management, PLOS One, Hospital, CEO, Death, COVID-19, EHR, Radiology, ADT, Safety, Organization, InterSystems, Pharmaceutical industry, Medical imaging, InterSystems, Greater Houston Healthconnect, INTERSYSTEMS, GREATER HOUSTON HEALTHCONNECT

Conducted using InterSystems HealthShare , the study examines more than one million COVID-19 cases to identify comorbidities that may represent risk factors for severe illness or death.

Key Points: 
  • Conducted using InterSystems HealthShare , the study examines more than one million COVID-19 cases to identify comorbidities that may represent risk factors for severe illness or death.
  • GHH is one of the largest HIEs in the United States and is connected to more than 95% of hospitals and healthcare systems in the greater Houston area.
  • A community-wide collaboration of specialists and researchers performed extensive analysis to determine symptom complexes and other risk factors resulting in bad outcomes.
  • Greater Houston Healthconnect is an independent, community-based organization whose mission is to enable care coordination and deliver value-added services for the benefit of its stakeholders.

VivoPower International PLC Announces Multi-National Distribution Deal for Tembo Electric Light Vehicles

Retrieved on: 
Tuesday, September 14, 2021
Standby Equity Distribution Agreement, NATM, Land cruiser, OEM, CEO, Information economy, Uncertainty, Distributor, Solution, Research, Originality, Forward-looking statement, Toyota Land Cruiser, Multinational, Securities and Exchange Commission (Philippines), Solar energy, NASDAQ, Communication, Growth, United Kingdom, GLOBE, Miner, GHH, Maintenance, Gesellschaft mit beschränkter Haftung, Technology, Original equipment manufacturer, Marketing, Company, Carbon, Mining, Risk, Industry, Distribution, Four-wheel drive, Partnership, LHD (load, haul, dump machine), Intermediary, Rail transport, Renewable energy, Real estate, Distribution (marketing)

Multi-national partnership across over 50 countries is the Companys fifth major distribution deal and largest to date by unit volumes.

Key Points: 
  • Multi-national partnership across over 50 countries is the Companys fifth major distribution deal and largest to date by unit volumes.
  • VivoPower now has Tembo distribution partners on six continents, with potential commitments totaling 7,825 e-LV conversion kits.
  • Under the agreement (the Distribution Agreement), GHH intends to purchase 3,000 Tembo e-LV conversion kits through to December 2026.
  • This Distribution Agreement marks VivoPowers fifth major distribution deal in 2021 for Tembo e-LV conversion kits, and its largest to date by e-LV kit volumes.

Green Hygienics Holdings Inc. to Present at 13th Annual LD Micro Main Event

Retrieved on: 
Monday, December 14, 2020
OTC Markets Group, GHH, Hemp, Hugo Gryn

SAN DIEGO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GHH" or the "Company"),is pleased to announce that it will present at the LD Micro's 13th Annual Main Event.

Key Points: 
  • SAN DIEGO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("GHH" or the "Company"),is pleased to announce that it will present at the LD Micro's 13th Annual Main Event.
  • The Company is scheduled to present today, Monday, December 14, 2020, at 1:20 P.M. EST.
  • A webcast of the presentation session and a copy of the company's latest investor presentation will be available on the company's website.
  • About Green Hygienics Holdings Inc.
    Green Hygienic Holdings Inc. (OTCQB: GRYN) (GHH or the Company), is a California based innovative technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.